Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory Relyvrio/Albrioza: New Drug for Amyotrophic Lateral Sclerosis Treatment September 29, 2022September 30, 2022 Amylyx Pharmaceuticals proposed mixture of sodium phenylbutyrate and tauroursodeoxycholic acid for ALS treatment.
